Cencora, Inc. — Company profile
Healthcare · Medical Distribution · United States
Last price 330.84 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 63.13B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Company profile
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
Details
| Name | Cencora, Inc. |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Employees | 51000 |
| Founded | 2001 |
| Ceo | Robert Mauch |
| Country | United States |
| Exchange | NYSE |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| Isin | US03073E1055 |
| Cusip | 03073E105 |
| Cik | 0001140859 |
| Sic | 5122 |
Key executives
| Name | Title |
|---|---|
| Dr. Robert P. Mauch Ph.D., PharmD | President, Chief Executive Officer and Director |
| Elizabeth S. Campbell J.D. | Executive Vice President and Chief Legal Officer |
| James F. Cleary Jr. | Advisor |
| Silvana Battaglia | Advisor |
| Eva C. Boratto | Executive Vice President and Chief Financial Officer |
| Lazarus Krikorian | Senior Vice President, Chief Accounting Officer and Corporate Controller |
| Pawan Singh Verma | Executive Vice President and Chief Data and Information Officer |
| Bennett S. Murphy | Senior Vice President Of Investor Relations and Enterprise Productivity and Treasury |
| Samantha L. Hammock | Executive Vice President and Chief Human Resources Officer |
| Richard Tremonte | Executive Vice President and President of U.S. Pharmaceuticals and Animal Health |
Contact
| Address | 1 West First Avenue, Conshohocken, Pennsylvania 19428-1800, United States |
| Phone | 610 727 7000 |
| Website | https://www.cencora.com |